An increasingly common cause of chronic liver disease in adults and children is nonalcoholic fatty liver disease (NAFLD). The diagnosis of NAFLD was traditionally based on the histopathological changes of the liver, evaluated by needle liver biopsy, an invasive method, with potential adverse effects and great inter and intraobserver variability. The noninvasive methods for the assessment of both fibrosis and steatosis in patients with NAFLD have increasingly been studied lately. Of these noninvasive methods, in this chapter, we will focus on the methods assessing the stiffness of liver parenchyma, i.e. elastographic methods, of which, the most widely used are ultrasound elastography techniques. We will discuss the principal elastographic me...
Purpose: This study prospectively assessed the performance of liver stiffness measurements using po...
Purpose: This study prospectively assessed the performance of liver stiffness measurements using po...
Introduction and aim: The gold-standard for fibrosis diagnosis in non-alcoholic fatty liver disease ...
The number of NAFLD patients is increasing in the developed world and non-invasive modalities for th...
Elastography is useful for diagnosing and grading hepatic fibrosis in patients with chronic liver di...
Non-alcoholic fatty liver disease (NAFLD) is a chronic disease which is currently the most common he...
Non-alcoholic fatty liver disease (NAFLD) is a relevant issue in public health owing to its epidemio...
Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease. Ultrasound-base...
Non-alcoholic fatty liver disease (NAFLD), and its progressive form, non-alcoholic steatohepatitis (...
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. Several...
Ultrasound-based elastography techniques have received considerable attention in the last years for ...
Non-alcoholic Fatty Liver Disease (NAFLD) is a chronic liver disease that is strongly related to ins...
AbstractDespite its invasiveness, liver biopsy is still considered the gold standard for the assessm...
Non-alcoholic fatty liver disease (NAFLD) is a relevant issue in public health owing to its epidemio...
NAFLD is a global epidemic. The prevalence of NAFLD is 20-30% in North America, northern Europe, Aus...
Purpose: This study prospectively assessed the performance of liver stiffness measurements using po...
Purpose: This study prospectively assessed the performance of liver stiffness measurements using po...
Introduction and aim: The gold-standard for fibrosis diagnosis in non-alcoholic fatty liver disease ...
The number of NAFLD patients is increasing in the developed world and non-invasive modalities for th...
Elastography is useful for diagnosing and grading hepatic fibrosis in patients with chronic liver di...
Non-alcoholic fatty liver disease (NAFLD) is a chronic disease which is currently the most common he...
Non-alcoholic fatty liver disease (NAFLD) is a relevant issue in public health owing to its epidemio...
Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease. Ultrasound-base...
Non-alcoholic fatty liver disease (NAFLD), and its progressive form, non-alcoholic steatohepatitis (...
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. Several...
Ultrasound-based elastography techniques have received considerable attention in the last years for ...
Non-alcoholic Fatty Liver Disease (NAFLD) is a chronic liver disease that is strongly related to ins...
AbstractDespite its invasiveness, liver biopsy is still considered the gold standard for the assessm...
Non-alcoholic fatty liver disease (NAFLD) is a relevant issue in public health owing to its epidemio...
NAFLD is a global epidemic. The prevalence of NAFLD is 20-30% in North America, northern Europe, Aus...
Purpose: This study prospectively assessed the performance of liver stiffness measurements using po...
Purpose: This study prospectively assessed the performance of liver stiffness measurements using po...
Introduction and aim: The gold-standard for fibrosis diagnosis in non-alcoholic fatty liver disease ...